Leading the way to safer medication
 Crosscheck  Recommender

Colchicine

Description

Colchicine is considered to act against the inflammatory response to urate crystals, by possibly inhibiting the migration of granulocytes into the inflamed area. Other properties of colchicine, such as interaction with the microtubules, could also contribute to the operation. Onset of action is approximately 12 hours after oral administration and is maximal after 1 to 2 days.

ATC Classification

Code
Title
Category
L01CC
Colchicine derivatives
L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01C Plant alkaloids and other natural products
M04AC01
Colchicine
M Musculo-skeletal system → M04 Antigout preparations → M04A Antigout preparations → M04AC Preparations with no effect on uric acid metabolism

Trade names

Trade name
Countries
COLCITEX

Singapore

COLCRYS

United States

COLCTAB

Austria

COLGOUT

Australia

GLOPERBA

United States

LENGOUT

Australia

MITIGARE

United States

Trade names (in combination): COLCHIMAX

Product Monographs

Monograph
Type
Country
COLCHICINE Tablet
MPI, EU: SmPC
UK

2D Molecule Structure

Unique Ingredient Identifier (UNII)

SML2Y3J35T - COLCHICINE

CAS Registry Number

64-86-8 - Colchicine

SNOMED-CT

387413002 - Colchicine (substance)

 
Next: Usage >